Star Source Multi Trade
104.50
-5.50(-5.00%)
Market Cap₹15.68 Cr
PE Ratio-1.36
IndustryHealthcare
Company Performance:
1D-5.00%
1M+19.84%
6M-16.40%
1Y-20.47%
5Y+330.93%
View Company Insightsright
More news about Star Source Multi Trade
05Jan 26
Star Source Multitrade Limited Announces Website Domain Transition
Star Source Multitrade Limited has notified BSE about its website domain change from thechemopharmalaboratoriesltd.com to starsourcemultitrade.com, effective January 05, 2025. The company has implemented permanent redirects to ensure seamless user access and maintains compliance with SEBI Regulation 46 requirements.
 no imag found
26Dec 25
Star Source Multi Trade Gets BSE Approval for Promoter Reclassification, Files Additional Disclosure Details
Star Source Multi Trade Limited has received BSE approval for promoter reclassification involving Shanta Somani and Citric India Limited moving to public shareholder category. The company also filed additional regulatory disclosure details on December 26, 2025, for three key management resignations that occurred in April 2025, including CEO, CFO, and Company Secretary positions, citing other commitments as the reason for departure.
 no imag found
23Sept 25
Chemo Pharma Laboratories Seeks Reclassification of Promoter Group Shareholder
Chemo Pharma Laboratories has applied to the BSE for reclassification of Ms. Shanta Somani from 'Promoter Group Shareholder' to 'Public Shareholder'. The application, made on September 10, 2025, is under Regulation 31A of SEBI LODR Regulations. Ms. Somani currently holds 0 shares (0.00% equity) in the company. The reclassification, if approved, may impact the company's promoter group structure and regulatory reporting.
 no imag found
12Sept 25
Chemo Pharma Laboratories Announces Key Leadership Changes in Compliance Function
Chemo Pharma Laboratories Limited has announced changes in its compliance leadership. Ms. Bhawna Rajput (ACS 72357) resigned as Company Secretary and Compliance Officer, citing preoccupation with other assignments. The Board immediately appointed Mr. Aditya Agarwal (ACS 53202) as her successor. Mr. Agarwal, a qualified Company Secretary with an MBA and M.Com degree, brings expertise in legal, secretarial, and listing compliances. The changes were approved in a Board meeting on September 12, 2025, and disclosed in compliance with SEBI regulations.
 no imag found
11Aug 25
Chemo Pharma Laboratories Receives Reclassification Request from Promoter Group Shareholder
Ms. Shanta Somani, a Promoter Group Shareholder of Chemo Pharma Laboratories Limited, has requested reclassification to the Public Shareholder category. The request, made on August 11, 2025, will be considered by the company's Board of Directors in an upcoming meeting. Managing Director Mr. Ruchit Mehta confirmed receipt of the request letter, and the company has assured compliance with all regulatory procedures.
 no imag found
31Jul 25
Chemo Pharma Laboratories Appoints New Statutory Auditor Amid Leadership Change
Chemo Pharma Laboratories Limited has announced a change in its statutory auditor. M/s Sanjay Rane & Associates LLP resigned citing pre-occupation with other assignments. The Board has recommended M/s. S S R V & Associates, Chartered Accountants, as the new statutory auditors, effective July 29, 2025, subject to shareholder approval. The new firm brings extensive experience in various financial areas. The transition complies with regulatory requirements, and no concerns were raised by the outgoing auditors.
 no imag found
24Jul 25
Chemo Pharma Laboratories' Statutory Auditors Resign Ahead of Term Completion
Sanjay Rane & Associates LLP, statutory auditors of Chemo Pharma Laboratories Limited, resigned effective July 23, 2025, citing pre-occupation with other assignments. This resignation comes nearly two years before their scheduled term completion. The auditors recently signed the FY 2024-25 audit report and assured no disputes with management or concerns about information suppression. Chemo Pharma has informed the Bombay Stock Exchange as per SEBI regulations but has not yet announced a replacement.
 no imag found
21Jul 25
Chemo Pharma Promoter Atibha Agriseeds Boosts Stake to 27.88% with Share Purchase
Atibha Agriseeds Private Limited, a promoter of Chemo Pharma Laboratories Ltd, has increased its stake in the company from 24.63% to 27.88%. The promoter acquired 48,781 equity shares (3.25% stake) through market purchases on the BSE for Rs 48.78 lakh on July 18, 2025. The transaction was disclosed to SEBI as per regulatory requirements. Ruchit Mehta holds positions in both companies, serving as Managing Director at Chemo Pharma and Director at Atibha Agriseeds.
 no imag found
Star Source Multi Trade
104.50
-5.50
(-5.00%)
1 Year Returns:-20.47%
Industry Peers
Sun Pharmaceutical
1,691.00
(+1.27%)
Divis Laboratories
6,387.00
(+1.61%)
Torrent Pharmaceuticals
4,151.00
(+1.63%)
Dr Reddys Laboratories
1,299.00
(+6.74%)
Lupin
2,355.70
(+2.07%)
Cipla
1,282.00
(+3.70%)
Zydus Life Science
951.70
(+2.34%)
Mankind Pharma
2,284.50
(+2.21%)
Aurobindo Pharma
1,436.40
(+1.07%)
Alkem Laboratories
5,517.50
(-1.95%)